kabutan

Kusurinomadoguchi, Inc. <5592> rises for fifth straight day as new users for prescription online service exceed plan, FY March 2026 results beat guidance

Fri Apr 24, 2026 9:37 am JST Catalyst

Kusurinomadoguchi, Inc. <5592> rose sharply, extending gains for a fifth consecutive day. Around 9:00 a.m., the company announced that its consolidated results for the fiscal year ending March 2026, currently being compiled, appear to have exceeded previous guidance. Revenue is expected to reach 12.33 billion yen (up 10.1% year-on-year), revised upward from the prior forecast of 12.3 billion yen. Operating profit is projected at 2.681 billion yen (up 37.3% year-on-year), raised from 2.45 billion yen, and net profit is estimated at 2.9 billion yen (up 42.6% year-on-year), up from 2.69 billion yen. The announcement attracted buying interest.

The upward revision was driven by the number of new users for the prescription online service in the media business exceeding plan, as well as the addition of two new companies as consolidated subsidiaries. Continued optimization of costs across group companies also contributed.

In line with the improved earnings, the company raised its year-end dividend forecast from 36 yen to 38 yen (compared to 27 yen in the previous fiscal year).

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles